Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...
Morningstar14d
Madrigal Pharmaceuticals Inc MDGL
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Investing14d
Madrigal Pharmaceuticals appoints new board member
CONSHOHOCKEN, Pa. - Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biotech company with a market capitalization of $7.27 billion and strong financial health indicators according to InvestingPro data, ...
Madrigal Pharmaceuticals appoints Fouse to its board of directors
Madrigal Pharmaceuticals (MDGL) announced it has appointed Jacqualyn Fouse, Ph.D. to its Board of Directors. Fred Craves, Ph.D. is retiring ...
Investing15d
Madrigal Pharmaceuticals appoints new board member
CONSHOHOCKEN, Pa. - Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biotech company with a market capitalization of $7.27 billion and strong financial health indicators according to InvestingPro ...
Morningstar15d
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated ...
manilatimes15d
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic ...